ACTIVASE

LOE Approaching

alteplase

BLASINGLE-USEVIALPriority Review
Approved
Nov 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
19

Mechanism of Action

CLINICAL PHARMACOLOGY Alteplase is an enzyme (serine protease) that has the property of fibrin-enhanced conversion of plasminogen to plasmin. It produces limited conversion of plasminogen in the absence of fibrin. Alteplase binds to fibrin in a thrombus and converts the entrapped plasminogen to…

Clinical Trials (5)

NCT05395351N/ACompleted

Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization

Started Nov 2022
113,035 enrolled
Stroke
NCT05401149N/ACompleted

Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients

Started Jul 2022
3,058 enrolled
Stroke
NCT04915729Phase 3Completed

A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity

Started Jun 2021
1,489 enrolled
Stroke
NCT04640194Phase 2/3Completed

A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

Started Dec 2020
104 enrolled
Acute Respiratory Distress Syndrome
NCT04419493Phase 1Completed

A Study in Healthy Men to Compare 2 Different Formulations of Alteplase

Started Jun 2020
30 enrolled
Healthy